GutCRINE

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

mbiomics

This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.

The Akkermansia Company

The company develops and sells pasteurised gut microbiome supplements to consumers and health professionals for weight management and metabolic health.

Jeevatva

This biotech company develops microbiome-based microbial products and prebiotics to restore human microbiome homeostasis for patients with metabolic conditions like type 2 diabetes.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

BEO Therapeutics

This company develops oral microbiome therapies to treat patients with gouty arthritis and chronic kidney disease by reducing metabolic waste products.

Bloom Science

This biotechnology company develops microbiome-based oral therapeutics for patients with rare neurological conditions and metabolic disorders like obesity and epilepsy.

Enterbiotix

This company develops orally administered microbiome therapeutics to treat patients with gastrointestinal conditions including irritable bowel syndrome and liver cirrhosis.